Please assess the completion status of the following clinical trial:

Trial Title: Trial Using Integuseal as Microbial Sealant for Arterial Bypass Surgery on Lower Extremities

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* planned supragenual of infragenual peripheral arterial bypass procedures with autologue or prosthetic graft~Exclusion Criteria:~* secondary procedures and suprainguinal procedures

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- No use of integuseal (Type: NO_INTERVENTION): None
- Use of Integuseal (Type: EXPERIMENTAL): Application of a layer of Integuseal (Cyanoacrylate) from a ready to use applicator preoperative before incision Polymerisation immobilise the bacteria that survived the conventional skin preparation This way there will be les contamination of the wound.

Based on this trial design, predict the completion outcome and termination type (if applicable).